[go: up one dir, main page]

NO20051232L - Topiske vannfrie og etanolfrie askomycinsammensetninger - Google Patents

Topiske vannfrie og etanolfrie askomycinsammensetninger

Info

Publication number
NO20051232L
NO20051232L NO20051232A NO20051232A NO20051232L NO 20051232 L NO20051232 L NO 20051232L NO 20051232 A NO20051232 A NO 20051232A NO 20051232 A NO20051232 A NO 20051232A NO 20051232 L NO20051232 L NO 20051232L
Authority
NO
Norway
Prior art keywords
ethanol
free
ascomycin
component
composition
Prior art date
Application number
NO20051232A
Other languages
English (en)
Norwegian (no)
Inventor
Katrin Kriwet
Dorothea Ledergerber
Jean-Claude Sonntag
Nabila Sekkat
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20051232L publication Critical patent/NO20051232L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20051232A 2002-08-14 2005-03-10 Topiske vannfrie og etanolfrie askomycinsammensetninger NO20051232L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0218996.7A GB0218996D0 (en) 2002-08-14 2002-08-14 Organic compounds
PCT/EP2003/008999 WO2004016289A1 (en) 2002-08-14 2003-08-13 Topical anhydrous and ethanol-free ascomycin compositions

Publications (1)

Publication Number Publication Date
NO20051232L true NO20051232L (no) 2005-05-12

Family

ID=9942370

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051232A NO20051232L (no) 2002-08-14 2005-03-10 Topiske vannfrie og etanolfrie askomycinsammensetninger

Country Status (23)

Country Link
US (1) US20050220850A1 (pl)
EP (1) EP1534339B1 (pl)
JP (1) JP2005537302A (pl)
KR (1) KR100624583B1 (pl)
CN (1) CN1674940A (pl)
AR (1) AR040859A1 (pl)
AT (1) ATE445416T1 (pl)
AU (1) AU2003258607B2 (pl)
BR (1) BR0313462A (pl)
CA (1) CA2495345A1 (pl)
DE (1) DE60329687D1 (pl)
EC (1) ECSP055597A (pl)
GB (1) GB0218996D0 (pl)
IL (1) IL166601A0 (pl)
MX (1) MXPA05001767A (pl)
NO (1) NO20051232L (pl)
NZ (1) NZ538138A (pl)
PE (1) PE20040330A1 (pl)
PL (1) PL373230A1 (pl)
RU (1) RU2343919C2 (pl)
TW (1) TW200410713A (pl)
WO (1) WO2004016289A1 (pl)
ZA (1) ZA200500815B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307866D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
ES2389443T3 (es) * 2004-04-08 2012-10-26 Meda Pharma S.À.R.L. Composición de espuma de pimecrolimus que contiene hexilenglicol, opcionalmente alcohol de oleílo, dimetilisosorbida y/o triglicéridos de cadena media
US20080207670A1 (en) * 2004-09-16 2008-08-28 Bayer Healthcare Ag Dermally Applicable Formulations For Treating Skin Diseases in Animals
GB0425255D0 (en) * 2004-11-16 2004-12-15 Novartis Ag Pharmaceutical composition
DE102005037844A1 (de) * 2005-08-04 2007-04-05 Intendis Gmbh Wasserfreies Mehr-Phasen-Gel-System
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
US9205080B2 (en) 2006-11-16 2015-12-08 Transderm, Inc. Methods of treating keratin hyperproliferation disorders using mTOR inhibitors
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
EP2948134B1 (en) 2013-01-24 2020-03-04 Palvella Therapeutics, Inc. Compositions for transdermal delivery of mtor inhibitors
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
FR3061009B1 (fr) * 2016-12-22 2020-09-25 Oreal Composition cosmetique comprenant une ou plusieurs huile(s) polaire(s), un monoalcool aliphatique en c2-c6 et un polyol, au moins un actif hydrophile, et comprenant moins de 7% en poids d’eau
FR3061008B1 (fr) * 2016-12-22 2020-05-01 L'oreal Composition cosmetique comprenant une ou plusieurs huile(s) polaire(s), un monoalcool aliphatique en c2-c6 et un polyol, et comprenant moins de 5% en poids d’eau
CN110520097B (zh) * 2017-01-06 2023-10-27 帕尔维拉治疗股份有限公司 Mtor抑制剂的无水组合物及其使用方法
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use
FR3104962B1 (fr) * 2019-12-20 2021-12-31 Oreal Composition cosmétique comprenant au moins une huile polaire, un monoalcool aliphatique, un mélange de polyols et au moins un actif hydrophile
CN116602914B (zh) * 2023-07-05 2024-02-13 江苏知原药业股份有限公司 一种皮炎用乳膏及其生产工艺及其生产设备

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
DE69125230T2 (de) * 1990-09-04 1997-07-10 Fujisawa Pharmaceutical Co Tricyclische Verbindungen enthaltende Salben
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
CA2183083C (en) * 1994-03-07 2006-01-03 Charles D. Ebert Drug-containing adhesive composite transdermal delivery device
ES2173978T3 (es) * 1994-10-26 2002-11-01 Novartis Ag Utilizacion de un alcohol graso insaturado.
GB2327610B (en) * 1994-11-04 1999-06-02 Novartis Ag Macrolide compositions
HUP0104452A3 (en) * 1998-04-27 2004-05-28 Fujisawa Pharmaceutical Co Medicinal compositions, containing tricyclo compounds
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ATE445416T1 (de) 2009-10-15
BR0313462A (pt) 2005-07-05
US20050220850A1 (en) 2005-10-06
AU2003258607A1 (en) 2004-03-03
ZA200500815B (en) 2006-07-26
KR20050042475A (ko) 2005-05-09
EP1534339A1 (en) 2005-06-01
ECSP055597A (es) 2005-04-18
WO2004016289A1 (en) 2004-02-26
AU2003258607B2 (en) 2007-01-04
GB0218996D0 (en) 2002-09-25
EP1534339B1 (en) 2009-10-14
MXPA05001767A (es) 2005-04-25
PE20040330A1 (es) 2004-07-15
KR100624583B1 (ko) 2006-09-15
TW200410713A (en) 2004-07-01
IL166601A0 (en) 2006-01-15
CA2495345A1 (en) 2004-02-26
JP2005537302A (ja) 2005-12-08
RU2005107317A (ru) 2005-10-10
CN1674940A (zh) 2005-09-28
NZ538138A (en) 2008-05-30
AR040859A1 (es) 2005-04-20
RU2343919C2 (ru) 2009-01-20
DE60329687D1 (de) 2009-11-26
PL373230A1 (pl) 2005-08-22

Similar Documents

Publication Publication Date Title
NO20051232L (no) Topiske vannfrie og etanolfrie askomycinsammensetninger
KR100830061B1 (ko) 이환식 화합물 조성물 및 이의 안정화 방법
CA2637274C (en) Soft-gelatin capsule formulation
EA018545B1 (ru) Терапевтические композиции
EA200301204A1 (ru) Фармацевтически активные производные нуклеозида, способ их получения, их применение (варианты) и содержащая их фармацевтическая композиция, способ профилактики и/или лечения заболеваний и нарушений млекопитающих (варианты), комбинация лекарственных средств и ее применение (варианты)
US5004730A (en) Polycyclic aromatic esters of macrolidic and lincosamidic antibiotics and pharmaceutical and cosmetic compositions containing them
JP2736258B2 (ja) マクロライドのレチノイン酸エステル、その製造方法及びこれを含有する化粧料組成物
US7355064B2 (en) Method for preparing 15-keto-prostaglandin E derivative
JP5390519B2 (ja) 11−デオキシ−プロスタグランジン化合物を含む医薬組成物およびその安定化方法
CA2445651C (en) Cathartic composition comprising halogenated prostaglandin derivatives
CA2637275C (en) Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
US20010046982A1 (en) Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension
AU2001233286A1 (en) Internal 1,15-lactones of fluprostenol and related prostaglandin F2alpha analogs and their use in the treatment of glaucoma and intraocular hypertension
AR033771A1 (es) Composicion farmaceutica
JPS55161877A (en) Low freezing point composition
EP2730283A1 (en) Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases
JPH01501204A (ja) 光学活性ビシクロ〔3.3.0〕オクタンジオンカルボン酸エステルの製造法
JPS5448782A (en) Deesterification of cephem compound ester

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application